A cardiometabolic risk phenotype index integrating insulin resistance, systemic inflammation, and psychological burden for mortality risk stratification in metabolic dysfunction-associated steatotic liver disease: an exploratory longitudinal analysis of a nationally representative cohort
The ISP index was positively associated with the risks of ACM and CVM among individuals with MASLD, but because it was constructed and internally evaluated within the same sample, its apparent predictive performance may be optimistic owing to overfitting.